|
1
|
Jasperson KW, Tuohy TM, Neklason DW and
Burt RW: Hereditary and familial colon cancer. Gastroenterology.
138:2044–2058. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kohlmann W: Lynch syndrome and breast
cancer risk: Weighing the data. JCO Precis Oncol. Feb 26–2020.Epub
ahead of print. View Article : Google Scholar
|
|
3
|
Cerretelli G, Ager A, Arends MJ and
Frayling IM: Molecular pathology of lynch syndrome. J Pathol.
250:518–531. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dodaro C, Grifasi C, Florio J, Santangelo
ML, Duraturo F, De Rosa M, Izzo P and Renda A: The role of mutation
analysis of the APC gene in the management of FAP patients. A
controversial issue. Ann Ital Chir. 87:321–325. 2016.PubMed/NCBI
|
|
5
|
Duraturo F, Liccardo R, De Rosa M and Izzo
P: Genetics, diagnosis and treatment of lynch syndrome: Old lessons
and current challenges. Oncol Lett. 17:3048–3054. 2019.
|
|
6
|
Duraturo F, Liccardo R, Cavallo A, De Rosa
M, Rossi GB and Izzo P: Multivariate analysis as a method for
evaluating the pathogenicity of novel genetic MLH1 variants in
patients with colorectal cancer and microsatellite instability. Int
J Mol Med. 36:511–517. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liccardo R, De Rosa M, Rossi GB,
Carlomagno N, Izzo P and Duraturo F: Incomplete segregation of MSH6
frameshift variants with phenotype of lynch syndrome. Int J Mol
Sci. 18:9992017. View Article : Google Scholar :
|
|
8
|
Liccardo R, De Rosa M, Izzo P and Duraturo
F: Novel MSH2 splice-site mutation in a young patient with lynch
syndrome. Mol Med Rep. 17:6942–6946. 2018.
|
|
9
|
Liccardo R, Della Ragione C, Mitilini N,
De Rosa M, Izzo P and Duraturo F: Novel variants of unknown
significance in the PMS2 gene identified in patients with
hereditary colon cancer. Cancer. Manag Res. 18:6719–6725. 2019.
|
|
10
|
Liccardo R, De Rosa M, Izzo P and Duraturo
F: Novel implications in molecular diagnosis of lynch syndrome.
Gastroenterol Res Pract. 2017:25950982017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Giardiello FM, Allen JI, Axilbund JE,
Boland CR, Burke CA, Burt RW, Church JM, Dominitz JA, Johnson DA,
Kaltenbach T, et al: Guidelines on genetic evaluation and
management of lynch syndrome: A consensus statement by the US
multi-society task force on colorectal cancer. Gastroenterology.
147:502–526. 2014. View Article : Google Scholar
|
|
12
|
Duraturo F, Cavallo A, Liccardo R, Cudia
B, De Rosa M, Diana G and Izzo P: Contribution of large genomic
rearrangements in italian lynch syndrome patients: Characterization
of a novel Alu-mediated deletion. Biomed Res Int. 2013:2198972013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tognetto A, Pastorino R, Castorina S,
Condorelli DF, DeCensi A, De Vito C, Magnano A, Scaldaferri F,
Villari P, Genuardi M and Boccia S: The current practice of lynch
syndrome diagnosis and management in Italy: A qualitative
assessment. Public Health Genomics. 22:189–207. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lynch PM: The hMSH2 and hMLH1 genes in
hereditary nonpolyposis colorectal cancer. Surg Oncol Clin N Am.
18:611–624. 2009. View Article : Google Scholar
|
|
15
|
Hendriks YM, Wagner A, Morreau H, Menko F,
Stormorken A, Quehenberger F, Sandkuijl L, Møller P, Genuardi M,
Van Houwelingen H, et al: Cancer risk in hereditary nonpolyposis
colorectal cancer due to MSH6 mutations: Impact on counseling and
surveillance. Gastroenterology. 127:17–25. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Senter L, Clendenning M, Sotamaa K, Hampel
H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN,
Lindor NM, et al: The clinical phenotype of lynch syndrome due to
germ-line PMS2 mutations. Gastroenterology. 135:419–428. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu Y, Berends MJ, Sijmons RH, Mensink RG,
Verlind E, Kooi KA, van der Sluis T, Kempinga C, van dDer Zee AG,
Hollema H, et al: A role for MLH3 in hereditary nonpolyposis
colorectal cancer. Nat Genet. 29:137–138. 2001. View Article : Google Scholar
|
|
18
|
Moreira L, Balaguer F, Lindor N, de la
Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L,
Gallinger S, Newcomb PA, et al: Identification of lynch syndrome
among patients with colorectal cancer. JAMA. 17:1555–1565. 2012.
View Article : Google Scholar
|
|
19
|
Gupta S, Provenzale D, Llor X, Halverson
AL, Grady W, Chung DC, Haraldsdottir S, Markowitz AJ, Slavin TP Jr,
Hampel H, et al: NCCN guidelines insights: Genetic/familial
high-risk assessment: Colorectal, version 2. 2019.J Natl Compr Canc
Netw. 17:1032–1041. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vasen HF, Mecklin JP, Khan PM and Lynch
HT: The International collaborative group on hereditary
non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum.
34:424–425. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vasen HF, Watson P, Mecklin JP and Lynch
HT: New clinical criteria for hereditary nonpolyposis colorectal
cancer (HNPCC, Lynch syndrome) Proposed By the International
Collaborative Group on HNPCC. Gastroenterology. 116:1453–1456.
1999. View Article : Google Scholar
|
|
22
|
Gonzaga-Jauregui C, Lupski JR and Gibbs
RA: Human genome sequencing in health and disease. Annu Rev Med.
63:35–61. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Turano M, Costabile V, Cerasuolo A,
Duraturo F, Liccardo R, Delrio P, Pace U, Rega D, Dodaro CA, Milone
M, et al: Characterisation of mesenchymal colon tumour-derived
cells in tumourspheres as a model for colorectal cancer
progression. Int J Oncol. 53:2379–2396. 2018.
|
|
24
|
Fecteau H, Vogel KJ, Hanson K and
Morrill-Cornelius S: The evolution of cancer risk assessment in the
era of next generation sequencing. J Genet Couns. 23:633–639. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mardis ER: A decade's perspective on DNA
sequencing technology. Nature. 470:198–203. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin EI, Tseng LH, Gocke CD, Reil S, Le DT,
Azad NS and Eshleman JR: Mutational profiling of colorectal cancers
with microsatellite instability. Oncotarget. 6:42334–42344. 2015.
View Article : Google Scholar
|
|
27
|
Kim JC, Choi JS, Roh SA, Cho DH, Kim TW
and Kim YS: Promoter methylation of specific genes is associated
with the phenotype and progression of colorectal adenocarcinomas.
Ann Surg Oncol. 17:1767–1776. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu C, Wang QS and Wang YJ: The CHEK2
I157T variant and colorectal cancer susceptibility: A systematic
review and meta-analysis. Asian Pac J Cancer Prev. 13:2051–2055.
2012. View Article : Google Scholar
|
|
29
|
Han P, Liu G, Lu X, Cao M, Yan Y, Zou J,
Li X and Wang G: CDH1 rs9929218 Variant at 16q22.1 contributes to
colorectal cancer susceptibility. Oncotarget. 26:47278–47286. 2016.
View Article : Google Scholar
|
|
30
|
Shenoy S: CDH1 (E-Cadherin) mutation and
gastric cancer: Genetics, molecular mechanisms and guidelines for
management. Cancer Manag Res. 13:10477–10486. 2019. View Article : Google Scholar
|
|
31
|
Elzagheid A, Buhmeida A, Laato M,
El-Faitori O, Syrjänen K, Collan Y and Pyrhönen S: Loss of
E-cadherin expression predicts disease recurrence and shorter
survival in colorectal carcinoma. APMIS. 120:539–548. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Berndt SI, Platz EA, Fallin MD, Thuita LW,
Hoffman SC and Helzlsouer KJ: Mismatch repair polymorphisms and the
risk of colorectal cancer. Int J Cancer. 120:1548–1554. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Orimo H, Nakajima E, Yamamoto M, Ikejima
M, Emi M and Shimada T: Association between single nucleotide
polymorphisms in the hMSH3 gene and sporadic colon cancer with
microsatellite instability. J Hum Genet. 45:228–230. 2000.
View Article : Google Scholar
|
|
34
|
Jafary F, Salehi M, Sedghi M, Nouri N,
Jafary F, Sadeghi F, Motamedi S and Talebi M: Association between
mismatch repair gene MSH3 Codons 1036 and 222 polymorphisms and
sporadic prostate cancer in the Iranian population. Asian Pac J
Cancer Prev. 13:6055–6057. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Duraturo F, Liccardo R, Cavallo A, De Rosa
M, Grosso M and Izzo P: Association of low-risk MSH3 and MSH2
variant alleles with lynch syndrome: Probability of synergistic
effects. Int J Cancer. 129:1643–1650. 2011. View Article : Google Scholar
|
|
36
|
Adam R, Spier I, Zhao B, Kloth M, Marquez
J, Hinrichsen I, Kirfel J, Tafazzoli A, Horpaopan S, Uhlhaas S, et
al: Exome sequencing identifies biallelic MSH3 germline mutations
as a recessive subtype of colorectal adenomatous polyposis. Am J
Hum Genet. 99:337–351. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Olkinuora A, Nieminen TT, Mårtensson E,
Rohlin A, Ristimäki A, Koskenvuo L, Lepistö A; Swedish Extended
Genetic Analysis of Colorectal Neoplasia (SWEN) Study Group;
Gebre-Medhin S, Nordling M and Peltomäki P: Biallelic germline
nonsense variant of MLH3 underlies polyposis predisposition. Genet
Med. 21:1868–1873. 2019. View Article : Google Scholar
|
|
38
|
Duraturo F, Liccardo R and Izzo P:
Coexistence of MLH3 germline variants in colon cancer patients
belonging to families with lynch syndrome-associated brain tumors.
J Neurooncol. 129:577–578. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Titze S, Peters H, Währisch S, Harder T,
Guse K, Buske A, Tinschert S and Harder A: Differential MSH2
promoter methylation in blood cells of Neurofibromatosis type 1
(NF1) patients. Eur J Hum Genet. 18:81–87. 2010. View Article : Google Scholar :
|
|
40
|
Richards S, Aziz N, Bale S, Bick D, Das S,
Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al:
Standards and guidelines for the interpretation of sequence
variants: A joint consensus recommendation of the American College
of medical genetics and genomics and the association for molecular
pathology. Genet Med. 17:405–424. 2015. View Article : Google Scholar :
|
|
41
|
Desmet FO, Hamroun D, Lalande M,
Collod-Béroud G, Claustres M and Béroud C: Human splicing finder:
An online bio-informatics tool to predict splicing signals. Nucleic
Acids Res. 37:e672009. View Article : Google Scholar
|
|
42
|
Ramensky V, Bork P and Sunyaev S: Human
non-synonymous SNPs: Server and survey. Nucleic Acids Res.
30:3894–3900. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rost B, Yachdav G and Liu J: The
predictprotein server. Nucleic Acids Res. 32:W321–W326. 2004.
View Article : Google Scholar :
|
|
44
|
Schwarz JM, Rödelsperger C, Schuelke M and
Seelow D: Mutationtaster evaluates disease-causing potential of
sequence alterations. Nat Methods. 7:575–576. 2010. View Article : Google Scholar
|
|
45
|
Choi Y, Sims GE, Murphy S, Miller JR and
Chan AP: Predicting the functional effect of amino acid
substitutions and indels. PLoS One. 7:e466882012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhunussova G, Afonin G, Abdikerim S,
Jumanov A, Perfilyeva A, Kaidarova D and Djansugurova L: Mutation
spectrum of cancer-associated genes in patients with early onset of
colorectal cancer. Front Oncol. 9:6732019. View Article : Google Scholar :
|
|
47
|
Liccardo R, Nolano A, Lambiase M, Della
Ragione C, De Rosa M, Izzo P and Duraturo F: MSH2 overexpression
due to an unclassified variant in 3-Untranslated region in a
patient with colon cancer. Biomedicines. 8:1672020. View Article : Google Scholar
|
|
48
|
Arora S, Huwe PJ, Sikder R, Shah M, Browne
AJ, Lesh R, Nicolas E, Deshpande S, Hall MJ, Dunbrack RL Jr and
Golemis EA: Functional analysis of rare variants in mismatch repair
proteins augments results from computation-based predictive
methods. Cancer Biol Ther. 18:519–533. 2017. View Article : Google Scholar :
|
|
49
|
Jia X, Burugula BB, Chen V, Lemons RM,
Jayakody S, Maksutova M and Kitzman JO: Massively parallel
functional testing of MSH2 missense variants conferring lynch
syndrome risk. Am J Hum Genet. 108:163–175. 2021. View Article : Google Scholar
|
|
50
|
Hegan DC, Narayanan L, Jirik FR, Edelmann
W, Liskay RM and Glazer PM: Differing patterns of genetic
instability in mice deficient in the mismatch repair genes Pms2,
Mlh1, Msh2, Msh3 and Msh6. Carcinogenesis. 27:2402–5408. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Loukola A, Vilkki S, Singh J, Launonen V
and Aaltonen LA: Germline and somatic mutation analysis of MLH3 in
MSI-positive colorectal cancer. Am J Pathol. 157:347–352. 2000.
View Article : Google Scholar
|
|
52
|
Turano M, Delrio P, Rega D, Cammarota F,
Polverino A, Duraturo F, Izzo P and De Rosa M: Promising colorectal
cancer biomarkers for precision prevention and therapy. Cancers
(Basel). 11:19322019. View Article : Google Scholar
|
